Galapagos | Utile Per Azione



Fiscal Calendario Efettivo Consenso Precedente Data
FY2025Q1 Mar/2025 -0.16 0.36 Apr/23 2025
FY2024Q4 Dec/2024 0.29 -0.36 2.39 Feb/12 2025
FY2024Q3 Sep/2024 -0.74 -0.75 0.39 Oct/30 2024
FY2024Q1 Jun/2024 0.11 0.11 0.08 Aug/01 2024
FY2024Q1 Mar/2024 0.36 0.36 0.35 May/02 2024
FY2023Q4 Dec/2023 2.39 2.39 -3.16 Feb/22 2024
FY2023Q3 Sep/2023 0.39 -1.03 0.33 Nov/02 2023
FY2023Q2 Jun/2023 0.08 -0.71 -0.29 Aug/03 2023
FY2023Q1 Mar/2023 0.35 -0.2 May/04 2023
FY2022Q4 Dec/2022 -3.16 -0.53 0.25 Feb/23 2023
FY2022Q3 Sep/2022 0.33 -0.80 -0.99 Nov/03 2022
FY2022Q2 Jun/2022 -0.29 -0.87 -0.98 Aug/04 2022

Eps Cambiamento Data
argenx SE USD 11.22 9.94 2024-12
AstraZeneca USD 2.09 0.01 2024-12
Biogen USD 3.44 0.64 2024-12
Genmab DKK 59.49 39.55 2024-12
Gilead Sciences USD 1.9 0.12 2024-12
GlaxoSmithKline GBP 0.23 0.27 2024-12
GRIFOLS EUR 0.22 0.06 2024-12
Hikma Pharmaceutical USD 0.6 0.41 2024-12
Incyte USD 1.43 0.36 2024-12
Merck EUR 2.07 0.23 2024-12
Neurocrine Biosciences USD 1 0.24 2024-12
Novartis USD 1.98 0.4 2024-12
Roche Holding CHF 8.57 1.66 2024-12
Sanofi EUR 1.31 1.55 2024-12
UCB EUR 2.89 0.8 2024-12
Vertex Pharmaceuticals USD 3.98 0.4 2024-12



Galapagos Utile Per Azione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.